Once-Weekly Dosage: Tirzepatide is administered once weekly as a subcutaneous injection, offering convenience and improved adherence compared to medications that require daily dosing
Follow @DrJillCarnahan | Shop Clean Supplements * These statements have not been evaluated by the Food and Drug Administration
Safer alternatives include optimising tirzepatide monotherapy with appropriate dose titration, structured NHS lifestyle programmes, licensed GLP-1 receptor agonists like semaglutide (Wegovy), or referral for bariatric surgery assessment
The most frequently reported side effects of semaglutide are gastrointestinal in nature
It stimulates GH release, which in turn promotes lipolysis the breakdown of stored fat for energy
(2019) further demonstrated that recombinant human GLP-1 (rhGLP-1) suppresses epithelial apoptosis and mitigates tubulointerstitial fibrosis via the PKA/PKC signaling pathway (Yin et al., 2019)